NASDAQ:AKU Akumin (AKU) Stock Price, News & Analysis → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free AKU Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$0.13▼$0.3652-Week Range N/AVolume8.54 million shsAverage Volume1.38 million shsMarket Capitalization$26.32 millionP/E RatioN/ADividend YieldN/APrice Target$0.25 Stock AnalysisStock Analysis Get Akumin alerts: Email Address Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About Akumin Stock (NASDAQ:AKU)Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.Read More Ad Gold Safe ExchangeGold Set to EXPLODE!Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! AKU Stock News HeadlinesFebruary 21, 2024 | finance.yahoo.comAKUMIN ANNOUNCES PARTNERSHIP WITH NORTHERN NEVADA SIERRA MEDICAL CENTER FOR RADIATION ONCOLOGY SERVICESFebruary 6, 2024 | finance.yahoo.comAkumin Inc. Completes Deleveraging Transaction, Becomes a Private Company Wholly-Owned by StonepeakMay 9, 2024 | InvestorPlace (Ad)Proof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…January 11, 2024 | fxstreet.com2023 corporate bankruptcies topped pandemic year numbersJanuary 10, 2024 | msn.comFACTBOX-US corporate bankruptcies hit 13-year peak in 2023December 13, 2023 | theglobeandmail.comAkumin: Top 10 Undervalued Healthcare Sector Stocks on TSX (AKU)December 12, 2023 | ca.finance.yahoo.comAKUMIN ANNOUNCES THIRD QUARTER 2023 RESULTSNovember 2, 2023 | finance.yahoo.comAkumin Inc. Provides Update on Trading on the Toronto Stock Exchange and Stockholder InformationMay 9, 2024 | InvestorPlace (Ad)Proof that the Musk/Bezos rivalry is about to hit a new levelElon Musk Humiliated Since Jeff Bezos and Elon Musk first met in 2004 — they've been involved in a bitter feud… from rockets, to electric vehicles to who's the world richest person…for going on two decades these two have been at each others throats…October 25, 2023 | msn.comFlorida-based radiology provider Akumin Imaging files for bankruptcy amid 'ransomware incident'October 23, 2023 | markets.businessinsider.comWhy EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day SessionOctober 23, 2023 | bizjournals.comMultimillion-dollar public health care company to become privately held firm amid bankruptcyOctober 23, 2023 | markets.businessinsider.comNasdaq Turns Higher; Akumin Shares JumpOctober 23, 2023 | morningstar.comNorth American Morning Briefing: 10-Year Treasury Yield Hits 5%October 23, 2023 | markets.businessinsider.comWhy Is Troika Media (TRKA) Stock Down 20% Today?October 23, 2023 | msn.comWhy Is Akumin (AKU) Stock Up 51% Today?October 21, 2023 | marketwatch.comAkumin Shares Rise 41% on Deal to Go PrivateOctober 21, 2023 | msn.comAkumin stock soars over 40% after company reaches agreement to go privateOctober 20, 2023 | marketwatch.comStocks to Watch: Great Ajax, Akumin, BioMarin PharmaceuticalOctober 18, 2023 | news.yahoo.comMedical provider Akumin turning away patients after apparent cyberattackOctober 16, 2023 | marketwatch.comAkumin Service Disrupted By CyberattackOctober 11, 2023 | msn.comThe largest cyberattack of its kind recently happened. Here’s how.September 14, 2023 | ca.finance.yahoo.comAkumin Inc. (AKU) Interactive Stock Chart - Yahoo FinanceAugust 10, 2023 | finanznachrichten.deAkumin Inc.: Akumin Announces Second Quarter 2023 Results, Revised FY23 Financial Outlook and Establishment of Special CommitteeAugust 7, 2023 | finance.yahoo.com15 Worst Performing Tech Stocks in 2023August 2, 2023 | theglobeandmail.comClosing Bell: Akumin Inc down on Tuesday (AKU)June 19, 2023 | benzinga.comBragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the FirmSee More Headlines Receive AKU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/13/2021Today5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:AKU CUSIPN/A CIK1776197 Webwww.akumin.com Phone(844) 730-0050FaxN/AEmployees3,631Year FoundedN/APrice Target and Rating Average Stock Price Target$0.25 High Stock Price Target$0.25 Low Stock Price Target$0.25 Consensus RatingReduce Rating Score (0-4)1.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($2.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-156,760,000.00 Net Margins-30.56% Pretax Margin-28.78% Return on Equity-167.86% Return on Assets-7.81% Debt Debt-to-Equity Ratio17.02 Current Ratio0.99 Quick Ratio0.99 Sales & Book Value Annual Sales$749.63 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$1.24 per share Price / BookN/AMiscellaneous Outstanding Shares91,170,000Free Float72,473,000Market Cap$26.32 million OptionableNot Optionable Beta-0.72 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Riadh Zine-El-Abidine (Age 51)Chairman & CEO Comp: $1.78MMr. David Krestchmer (Age 65)Chief Financial Officer Comp: $580.51kMr. Krishna Kumar AnanthasubramanianPres & COOMr. Paul Nelis (Age 55)Chief Information Officer Darren SpeedChief Compliance OfficerMs. Tracy Wiese (Age 54)Chief Strategy & Marketing Officer Ms. Holly Huso (Age 58)Enterprise Sales Officer Ms. Laurie R. Miller (Age 56)Chief HR Officer Mr. Mohammad SaleemSr. VP of Financial ReportingMr. Christopher FitzgeraldChief Revenue OfficerMore ExecutivesKey CompetitorsExagenNASDAQ:XGNDermTechNASDAQ:DMTKPsychemedicsNASDAQ:PMDBioNexus Gene LabNASDAQ:BGLCEnzo BiochemNYSE:ENZView All Competitors AKU Stock Analysis - Frequently Asked Questions Should I buy or sell Akumin stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akumin in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" AKU shares. View AKU analyst ratings or view top-rated stocks. What is Akumin's stock price target for 2024? 2 equities research analysts have issued twelve-month price objectives for Akumin's stock. Their AKU share price targets range from $0.25 to $0.25. On average, they predict the company's stock price to reach $0.25 in the next twelve months. View analysts price targets for AKU or view top-rated stocks among Wall Street analysts. How were Akumin's earnings last quarter? Akumin Inc. (NASDAQ:AKU) posted its earnings results on Monday, December, 13th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.43) by $0.41. The company earned $108.18 million during the quarter, compared to analyst estimates of $109.25 million. Akumin had a negative trailing twelve-month return on equity of 167.86% and a negative net margin of 30.56%. This page (NASDAQ:AKU) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akumin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
